Abcombi Biosciences

company

About

Abcombi Biosciences is a pre-clinical vaccine and therapeutic development company.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$225K
Industries
Biotechnology,Medical,Robotics
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

Abcombi Biosciences was formed on June 22nd, 2015 based off of research conducted in the Chemical & Biological Engineering Department at the University at Buffalo. Our corporate headquarters are located in Buffalo, New York in Baird Research Park.

Abcombi Biosciences is a pre-clinical vaccine and therapeutic development company dedicated to delivering “smarter” vaccine and anti-infective solutions. To accomplish this, we have developed key technologies and analytical strategies to facilitate our unique protection strategies:

- Their novel biofilm model that mimics the natural progression of disease for colonizing bacteria such Streptococcus pneumoniae and Staphylococcus aureus.
Bioinformatics, in conjunction with our biofilm model, help to identify antigens associated with specific stages of disease progression.

- A novel coupling mechanism that removes the need for complex chemistry to manufacture polysaccharide conjugate vaccines.

- A broad-spectrum RNA-based therapy for treating influenza infections.

At Abcombi, we harness these potent tools to provide universally protective interventions for complex diseases such as pneumonia and influenza.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$225K
Abcombi Biosciences has raised a total of $225K in funding over 2 rounds. Their latest funding was raised on Dec 12, 2016 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 12, 2016 Grant $225K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Abcombi Biosciences is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant